Tranexamic acid influences the immune response, but not bacterial clearance in a model of post-traumatic brain injury pneumonia

Abstract The antifibrinolytic agent, tranexamic acid (TXA), an inhibitor of plasmin formation, currently is evaluated to reduce bleeding in various conditions, including traumatic brain injury (TBI...